BSE filing, NSE: CONCORD. Summary written from the filing by ALFA Finder's alert engine.
Concord Drugs Ltd: key numbers
- Share price
- ₹63.55
- Market cap
- ₹83.73 Cr
- Revenue (annual)
- ₹78.74 Cr
- Net profit (annual)
- ₹1.06 Cr
- P/E (TTM)
- 40.8×Sector 45.9×
- Promoter holding
- 45.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Drugs Ltd
All →Concord Drugs Other Announcement
Concord Drugs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Concord Drugs Other Announcement
Concord Drugs Limited is notifying shareholders about the annual report web-link as per Regulation 36(1)(b). Shareholders are urged to update their email addresses.
Concord Drugs Annual Report
Concord Drugs Limited submitted its 31st Annual Report for FY 2025-26 and notice of the 31st Annual General Meeting scheduled for 30th September 2026.
Concord Drugs Annual General Meeting
Concord Drugs approved the notice for its 31st AGM on September 30, 2026. The board also finalized director re-appointments and set book closure dates.
Concord Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 1000.0% YoY
Concord Drugs Ltd reported revenue from operations of ₹20.9 Cr (+53.7% YoY) and net profit of ₹1.1 Cr (+1000.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +1000.0% YoY
Concord Drugs Board Meeting Date
Concord Drugs Limited scheduled a board meeting on August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other annual general meeting announcements
All →Cedaar Textile Annual General Meeting
Cedaar Textile filed the summary of proceedings of its 6th AGM held on 31 October 2026 via VC/OAVM. The AGM covered routine items, director and auditor appointments, and an IPO objects variation.
Sotac Pharmaceuticals Annual General Meeting
Sotac's EGM sought shareholder approval to raise authorised share capital from Rs.11.5 crore to Rs.15 crore. The video-conference meeting had one resolution.
Jhaveri Credits & Capital Annual General Meeting
Jhaveri Credits and Capital disclosed postal ballot voting results and the scrutinizer's report. Shareholders approved a change of the main object clause and a change of company name.
Aarti Industries Annual General Meeting
Aarti Industries shareholders held an EGM on October 31, 2026 and considered a special resolution. The resolution enables raising up to Rs. 1,000 crore through QIP, private placement or preferential issue, in one or more tranches.
Raymond Annual General Meeting
Raymond seeks shareholder approval via postal ballot to rename itself Raymond Aerospace, Defence & Engineering Limited. E-voting runs November 1 to 30, 2026.
Shriram Finance Annual General Meeting
Shriram Finance sent a postal ballot notice seeking approval to issue up to Rs.35,000 Crore of private placement debentures. Voting runs 31 October to 29 November 2026.
- Value
- ₹35,000 Cr
- Execution
- One year from the date of passing of the resolution